{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/PFE/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-24T18:55:04.458Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":8278,"canonical_name":"PFIZER INC","cik":"0000078003","uei":null,"lei":null,"duns":null,"ticker":"PFE"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"clinical":100,"fda":1,"sec":18,"court":8,"contracts":1},"count":100,"timeline":[{"ts":"2026-10-22","kind":"clinical.trial","reporter":"Pfizer","title":"A Study of a Medicine Called Atirmociclib in Combination With Giredestrant in Adult Participants With ER-positive, HER2-negative Early-stage Breast Cancer","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07890597","excerpt":"[\"Early Breast Cancer\",\"Estrogen Receptor Positive (ER+), Human Epidermal Growth Factor Receptor 2 Negative (HER2-)\"]","importance":60},{"ts":"2026-10-21","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Older Adults","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07885956","excerpt":"[\"Respiratory Syncytial Virus (RSV)\"]","importance":60},{"ts":"2026-10-21","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Abrocitinib in People With Severe Atopic Dermatitis Who Have Switched From Other Therapies","security_title":null,"status":"NOT_YET_RECRUITING","accession_number":"NCT07887867","excerpt":"[\"Dermatitis, Atopic\"]","importance":25},{"ts":"2026-10-19","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Do Not Use a Breathing Machine (PAP) (VESPER-OSA 2)","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07881757","excerpt":"[\"Apnea\",\"Sleep Disorders\",\"Overweight and/or Obesity\"]","importance":60},{"ts":"2026-10-19","kind":"clinical.trial","reporter":"Pfizer","title":"A Phase IV Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma That is Not Responding to Four or More Standard Treatments or Has Come Back After Several Standard Treatments","security_title":"PHASE4","status":"NOT_YET_RECRUITING","accession_number":"NCT07881835","excerpt":"[\"Relapsed/Refractory Multiple Myeloma\",\"Multiple Myeloma\"]","importance":25},{"ts":"2026-10-15","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared to Placebo in Chinese Adults With Overweight or Obesity","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07874633","excerpt":"[\"Obesity\",\"Overweight\"]","importance":60},{"ts":"2026-10-15","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How Different Amounts of the Study Medicine Called PF-08656795 Are Tolerated and Act in Adults With Overweight or Obesity","security_title":"PHASE1","status":"NOT_YET_RECRUITING","accession_number":"NCT07876518","excerpt":"[\"Overweight and/or Obesity\"]","importance":30},{"ts":"2026-10-15","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How Different Forms of the Study Medicine Called Berobenatide is Taken up Into the Blood in Adults With Overweight or Obesity","security_title":"PHASE1","status":"NOT_YET_RECRUITING","accession_number":"NCT07876531","excerpt":"[\"Overweight and/or Obesity\",\"Healthy Participants\"]","importance":30},{"ts":"2026-10-09","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Safety and Immune Responses of RSVpreF in Older Adults","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07819097","excerpt":"[\"Adult\",\"Healthy Participants\"]","importance":60},{"ts":"2026-10-09","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called Tilrekimig ( PF-07275315) in People With Severe Asthma","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07869043","excerpt":"[\"Asthma\"]","importance":60},{"ts":"2026-10-08","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07823608","excerpt":"[\"Apnea\",\"Sleep Disorders\",\"Overweight and/or Obesity\"]","importance":60},{"ts":"2026-10-06","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07772921","excerpt":"[\"Asthma\"]","importance":60},{"ts":"2026-10-06","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07783425","excerpt":"[\"Atopic Dermatitis\"]","importance":60},{"ts":"2026-10-06","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Outcomes Between Study Medicines, Enzalutamide and Darolutamide Among Men With Metastatic Castration Sensitive Prostate Cancer (mCSPC)","security_title":null,"status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT07779590","excerpt":"[\"Metastatic Castration Sensitive Prostate Cancer (mCSPC)\"]","importance":25},{"ts":"2026-10-05","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine (Called Marstacimab) in People With Hemophilia A or B","security_title":null,"status":"NOT_YET_RECRUITING","accession_number":"NCT07859527","excerpt":"[\"Hemophilia\"]","importance":25},{"ts":"2026-10-01","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoimmune Diseases","security_title":"PHASE1,PHASE2","status":"NOT_YET_RECRUITING","accession_number":"NCT07782450","excerpt":"[\"Systemic Lupus Erythematosus\",\"Rheumatoid Arthritis\",\"Idiopathic Inflammatory Myositis\",\"Systemic Sclerosis\"]","importance":45},{"ts":"2026-10-01","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy Adults","security_title":"PHASE1","status":"COMPLETED","accession_number":"NCT07597928","excerpt":"[\"Healthy Adults\",\"Healthy\"]","importance":30},{"ts":"2026-09-29","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07845500","excerpt":"[\"Obesity\",\"Overweight and/or Obesity\",\"Overweight\",\"Treatment Of Obesity\"]","importance":60},{"ts":"2026-09-29","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called PF-08653944 in Otherwise Healthy Chinese Adults With Overweight or Obesity","security_title":"PHASE1","status":"NOT_YET_RECRUITING","accession_number":"NCT07845513","excerpt":"[\"Overweight\",\"Obesity\",\"Healthy Adults\"]","importance":30},{"ts":"2026-09-28","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07595549","excerpt":"[\"Obesity\",\"Overweight and/or Obesity\",\"Overweight\"]","importance":60},{"ts":"2026-09-25","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07729462","excerpt":"[\"Preventive Treatment of Migraine\"]","importance":60},{"ts":"2026-09-25","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised Adults","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07768345","excerpt":"[\"Respiratory Syncytial Virus (RSV)\"]","importance":60},{"ts":"2026-09-25","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07792954","excerpt":"[\"Obesity\",\"Overweight\"]","importance":60},{"ts":"2026-09-25","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About Safety and Effects of Once-monthly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JM)","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07794774","excerpt":"[\"Obesity\"]","importance":60},{"ts":"2026-09-25","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About Safety and Effects of Once-weekly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JW)","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07794761","excerpt":"[\"Obesity\"]","importance":60},{"ts":"2026-09-25","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight Loss","security_title":"PHASE1","status":"NOT_YET_RECRUITING","accession_number":"NCT07663630","excerpt":"[\"Non-small Cell Lung Cancer (NSCLC)\",\"Cachexia\"]","importance":30},{"ts":"2026-09-25","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine","security_title":"PHASE4","status":"RECRUITING","accession_number":"NCT07609914","excerpt":"[\"Acute Treatment of Migraine\"]","importance":25},{"ts":"2026-09-24","kind":"clinical.trial","reporter":"Pfizer","title":"A Phase 3 Study in India to Describe the Safety and Immunogenicity of RSVpreF","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07653100","excerpt":"[\"Respiratory Syncytial Virus (RSV)\"]","importance":60},{"ts":"2026-09-24","kind":"clinical.trial","reporter":"Pfizer","title":"Study to Learn About a Respiratory Syncytial Virus Vaccine in Children at High Risk of RSV Disease","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07839871","excerpt":"[\"Respiratory Syncytial Virus (RSV)\"]","importance":60},{"ts":"2026-09-24","kind":"clinical.trial","reporter":"Pfizer","title":"A Continuation Study of Tilrekimig in Adults With Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About This Medicine When Used for a Long Period of Time","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07839884","excerpt":"[\"Moderate to Severe Chronic Obstructive Pulmonary Disease\"]","importance":60},{"ts":"2026-09-24","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India","security_title":"PHASE4","status":"RECRUITING","accession_number":"NCT07685769","excerpt":"[\"Acute Treatment of Migraine\"]","importance":25},{"ts":"2026-09-23","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to Adults","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07794748","excerpt":"[\"Pneumococcal Disease\"]","importance":60},{"ts":"2026-09-23","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How Different Amounts of the Study Medicine Called PF-08642534 Are Tolerated and Act in the Body of People Who Have Obesity","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07731139","excerpt":"[\"Obesity\"]","importance":30},{"ts":"2026-09-22","kind":"clinical.trial","reporter":"Pfizer","title":"Real-World Effectiveness of Ritlecitinib in Alopecia Areata Patients in the US: A Retrospective Analysis Using EHR and Claims Data","security_title":null,"status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT07821216","excerpt":"[\"Alopecia Areata\"]","importance":25},{"ts":"2026-09-16","kind":"clinical.trial","reporter":"Pfizer","title":"Abrocitinib Treatment of Atopic Dermatitis in Children 2 to Less Than 6 Years of Age","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07823595","excerpt":"[\"Atopic Dermatitis\"]","importance":60},{"ts":"2026-09-10","kind":"clinical.trial","reporter":"Pfizer","title":"A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07733765","excerpt":"[\"Alopecia Areata\"]","importance":60},{"ts":"2026-09-09","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How the Study Medicine Called PF-08653945 is Taken up Into the Blood in Adults With Overweight or Obesity","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07725809","excerpt":"[\"Overweight\",\"Obesity\",\"Healthy\"]","importance":30},{"ts":"2026-09-08","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07629440","excerpt":"[\"Pneumococcal Disease\"]","importance":60},{"ts":"2026-09-04","kind":"fda.recall","reporter":"Pfizer","title":"Class II","security_title":"Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC 0409-5820-11, Carton NDC 0409-5820-01.","excerpt":"Lack of Assurance of Sterility","accession_number":"D-0853-2026","status":"Ongoing","product_type":"drug","importance":60},{"ts":"2026-09-04","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07765888","excerpt":"[\"Atopic Dermatitis\"]","importance":60},{"ts":"2026-09-04","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults","security_title":"PHASE1","status":"COMPLETED","accession_number":"NCT07594769","excerpt":"[\"Migraine\"]","importance":30},{"ts":"2026-09-04","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Single Dose Pharmacokinetics of Study Medicine Called Tilrekimig in Healthy Adults When Co-Mixed With rHuPH20","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07792941","excerpt":"[\"Healthy\"]","importance":30},{"ts":"2026-09-02","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07660731","excerpt":"[\"Healthy Volunteer Study\",\"Healthy Adults\",\"Healthy Participants\",\"Asthma\"]","importance":30},{"ts":"2026-08-31","kind":"clinical.trial","reporter":"Pfizer","title":"Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07660198","excerpt":"[\"Pneumococcal Disease\"]","importance":60},{"ts":"2026-08-31","kind":"sec.filing","form_type":"N-PX","title":"N-PX — PFIZER INC — 2026-08-31","url_slug":"/sec/cik-0000078003/n-px/0000078003-26-000111","accession_number":"0000078003-26-000111","importance":30},{"ts":"2026-08-28","kind":"clinical.trial","reporter":"Pfizer","title":"Tucatinib Continuation Study","security_title":"PHASE4","status":"NOT_YET_RECRUITING","accession_number":"NCT07768358","excerpt":"[\"HER2-positive Breast Cancer\",\"Cervical Cancer\",\"Biliary Tract Neoplasms\",\"Urothelial Cancer\",\"Advanced Non-Small Cell Lung Cancer\",\"Gastric or Gastroesophageal Junction Adenocarcinoma (GEC)\",\"Colorectal Cancer\"]","importance":25},{"ts":"2026-08-21","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How the Study Medicine Called Atirmociclib is Handled by the Body in People With Normal Liver Function and Different Levels of Liver Disease","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07677358","excerpt":"[\"Hepatic Impairment\",\"Healthy, Hepatic Insufficiency\",\"Healthy Adults\"]","importance":30},{"ts":"2026-08-20","kind":"clinical.trial","reporter":"Pfizer","title":"Real-World Effectiveness of RSV Vaccines Among Adults Using Target Trial Emulation in Epic Cosmos","security_title":null,"status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT07673081","excerpt":"[\"Respiratory Syncytial Virus (RSV)\"]","importance":25},{"ts":"2026-08-17","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Safety of PENBRAYA During Pregnancy","security_title":null,"status":"RECRUITING","accession_number":"NCT07768163","excerpt":"[\"Meningococcal Disease\"]","importance":25},{"ts":"2026-08-13","kind":"sec.filing","form_type":"13F-HR","title":"13F-HR — PFIZER INC — 2026-08-13","url_slug":"/sec/cik-0000078003/13f-hr/0000078003-26-000102","accession_number":"0000078003-26-000102","importance":30},{"ts":"2026-08-12","kind":"sec.insider.p","reporter":"BOURLA ALBERT","title":"Chairman & CEO","shares":38000,"price_per_share":26.34,"usd_value":1000920,"security_title":"Common Stock","importance":51.00092},{"ts":"2026-08-10","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Evaluate 20vPnC in Healthy Chinese Infants","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07754539","excerpt":"[\"Pneumococcal Diseases\"]","importance":60},{"ts":"2026-08-05","kind":"sec.insider.p","reporter":"BLAYLOCK RONALD E","title":null,"shares":39231,"price_per_share":25.46,"usd_value":998821,"security_title":"Common Stock","importance":50.99882126},{"ts":"2026-08-05","kind":"sec.insider.p","reporter":"Buckley Mortimer J","title":null,"shares":37632,"price_per_share":25.52,"usd_value":960369,"security_title":"Common Stock","importance":50.96036864},{"ts":"2026-08-05","kind":"sec.insider.s","reporter":"DAMICO JENNIFER B.","title":"SVP & Controller","shares":3278,"price_per_share":25.4,"usd_value":83261,"security_title":"Common Stock","importance":35.0832612},{"ts":"2026-08-04","kind":"sec.filing","form_type":"10-Q","title":"10-Q — PFIZER INC — 2026-08-04","url_slug":"/sec/cik-0000078003/10-q/0000078003-26-000095","accession_number":"0000078003-26-000095","importance":45},{"ts":"2026-08-04","kind":"sec.filing","form_type":"8-K","title":"8-K — PFIZER INC — 2026-08-04","url_slug":"/sec/cik-0000078003/8-k/0000078003-26-000094","accession_number":"0000078003-26-000094","importance":35},{"ts":"2026-07-28","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About How Food Affects the Uptake of Study Medicine Prifetrastat Into the Blood in Healthy Adults","security_title":"PHASE1","status":"NOT_YET_RECRUITING","accession_number":"NCT07731100","excerpt":"[\"Healthy Adults\"]","importance":30},{"ts":"2026-07-23","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About How Different Forms of Study Medicine Prifetrastat Are Taken Up Into the Blood in Healthy Adults","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07721402","excerpt":"[\"Healthy Participant\"]","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — BOURLA ALBERT — 2026-07-01","url_slug":"/sec/cik-0001595703/4/0001225208-26-006273","accession_number":"0001225208-26-006273","importance":30},{"ts":"2026-06-26","kind":"court.docket","reporter":"flnd","title":"APPLEGATE v. PFIZER INC","security_title":"367 Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability","excerpt":"28:1332 Diversity-Product Liability","accession_number":"3:26-cv-04427","product_type":"Margaret Catharine Rodgers","importance":45},{"ts":"2026-06-24","kind":"court.docket","reporter":"flnd","title":"ADAMS WISE v. PFIZER INC","security_title":"367 Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability","excerpt":"28:1332 Diversity-Product Liability","accession_number":"3:26-cv-04390","product_type":"Margaret Catharine Rodgers","importance":45},{"ts":"2026-06-23","kind":"court.docket","reporter":"flnd","title":"WALKER v. PFIZER INC","security_title":"367 Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability","excerpt":"28:1332 Diversity-Product Liability","accession_number":"3:26-cv-04358","product_type":"Margaret Catharine Rodgers","importance":45},{"ts":"2026-06-19","kind":"court.docket","reporter":"flnd","title":"MOORE v. PFIZER INC","security_title":"367 Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability","excerpt":"28:1332 Diversity-Product Liability","accession_number":"3:26-cv-04320","product_type":"Margaret Catharine Rodgers","importance":45},{"ts":"2026-06-19","kind":"court.docket","reporter":"flnd","title":"DAVIS v. PFIZER INC","security_title":"367 Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability","excerpt":"28:1332 Diversity-Product Liability","accession_number":"3:26-cv-04321","product_type":"Margaret Catharine Rodgers","importance":45},{"ts":"2026-06-18","kind":"court.docket","reporter":"flnd","title":"SMITH v. PFIZER INC","security_title":"367 Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability","excerpt":"28:1332 Diversity-Product Liability","accession_number":"3:26-cv-04302","product_type":"Margaret Catharine Rodgers","importance":45},{"ts":"2026-06-18","kind":"sec.filing","form_type":"8-K","title":"8-K — PFIZER INC — 2026-06-18","url_slug":"/sec/cik-0000078003/8-k/0000078003-26-000085","accession_number":"0000078003-26-000085","importance":35},{"ts":"2026-06-18","kind":"sec.filing","form_type":"8-K","title":"8-K — PFIZER INC — 2026-06-18","url_slug":"/sec/cik-0000078003/8-k/0000078003-26-000087","accession_number":"0000078003-26-000087","importance":35},{"ts":"2026-06-16","kind":"sec.filing","form_type":"11-K","title":"11-K — PFIZER INC — 2026-06-16","url_slug":"/sec/cik-0000078003/11-k/0000078003-26-000078","accession_number":"0000078003-26-000078","importance":30},{"ts":"2026-06-16","kind":"sec.filing","form_type":"11-K","title":"11-K — PFIZER INC — 2026-06-16","url_slug":"/sec/cik-0000078003/11-k/0000078003-26-000080","accession_number":"0000078003-26-000080","importance":30},{"ts":"2026-06-09","kind":"court.docket","reporter":"flnd","title":"DANIELS v. PFIZER INC","security_title":"367 Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability","excerpt":"28:1332 Diversity-Product Liability","accession_number":"3:26-cv-04072","product_type":"Margaret Catharine Rodgers","importance":45},{"ts":"2026-06-09","kind":"sec.insider.s","reporter":"DAMICO JENNIFER B.","title":"SVP & Controller","shares":2000,"price_per_share":25.7,"usd_value":51400,"security_title":"Common Stock","importance":35.0514},{"ts":"2026-06-09","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn if the Study Medicine Called Fluconazole Changes How the Other Body Processes the Study Medicine PF-07248144","security_title":"PHASE1","status":"COMPLETED","accession_number":"NCT07636018","excerpt":"[\"Healthy Adults\"]","importance":30},{"ts":"2026-05-25","kind":"court.docket","reporter":"flnd","title":"DOLMAN v. PFIZER INC","security_title":"367 Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability","excerpt":"28:1332 Diversity-Product Liability","accession_number":"3:26-cv-03893","product_type":"Margaret Catharine Rodgers","importance":45},{"ts":"2026-05-18","kind":"clinical.trial","reporter":"Pfizer","title":"Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults","security_title":"PHASE3","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT04370054","excerpt":"[\"Hemophilia A\"]","importance":60},{"ts":"2026-05-18","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07400653","excerpt":"[\"Obesity\",\"Overweight and/or Obesity\",\"Overweight\",\"Diabetes, Type 2\",\"Type 2 Diabetes\"]","importance":60},{"ts":"2026-05-18","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity","security_title":"PHASE1","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT07400679","excerpt":"[\"Overweight\",\"Obesity\",\"Healthy\"]","importance":30},{"ts":"2026-05-18","kind":"clinical.trial","reporter":"Pfizer","title":"Vyndaqel Capsules Special Investigation (ATTR-CM)","security_title":null,"status":"COMPLETED","accession_number":"NCT04108091","excerpt":"[\"Transthyretin (TTR) Amyloid Cardiomyopathy\"]","importance":25},{"ts":"2026-05-18","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.","security_title":null,"status":"RECRUITING","accession_number":"NCT07152119","excerpt":"[\"Severe Alopecia Areata\"]","importance":25},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07013474","excerpt":"[\"COVID-19 Infection\"]","importance":60},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT06698796","excerpt":"[\"Dermatomyositis\",\"Polymyositis\"]","importance":60},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Pfizer","title":"This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07028853","excerpt":"[\"Metastatic Castration Sensitive Prostate Cancer (mCSPC)\",\"Hormone Sensitive Prostate Cancer\",\"Prostate Cancer\",\"Cancer of the Prostate\"]","importance":60},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Pfizer","title":"A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT06866405","excerpt":"[\"RSV Infection\"]","importance":60},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis","security_title":"PHASE2","status":"RECRUITING","accession_number":"NCT05287126","excerpt":"[\"Ulcerative Colitis\"]","importance":45},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Pfizer","title":"Relative Bioavailability and Impact of Rabeprazole for PF-07799933, Food-Effect for PF-07799933 and PF-07799544","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07563894","excerpt":"[\"Healthy\"]","importance":30},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine NURTEC® ODT 75 mg After it is Released Into the Markets in Korea","security_title":null,"status":"NOT_YET_RECRUITING","accession_number":"NCT07497854","excerpt":"[\"Migraine With or Without Aura\"]","importance":25},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.","security_title":null,"status":"RECRUITING","accession_number":"NCT06587035","excerpt":"[\"Dwarfism, Pituitary\"]","importance":25},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Pfizer","title":"Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy","security_title":null,"status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT06647654","excerpt":"[\"Respiratory Syncytial Virus\",\"Respiratory Tract Diseases\"]","importance":25},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07160244","excerpt":"[\"Healthy\"]","importance":60},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT05623020","excerpt":"[\"Multiple Myeloma\"]","importance":60},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07543380","excerpt":"[\"Respiratory Syncytial Virus (RSV)\"]","importance":60},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT06679140","excerpt":"[\"COVID-19 SARS-CoV-2 Infection\"]","importance":60},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL","security_title":"PHASE2","status":"RECRUITING","accession_number":"NCT05748171","excerpt":"[\"ACUTE LYMPHOBLASTIC LEUKEMIA\"]","importance":45},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT05355701","excerpt":"[\"Melanoma\",\"Non-Small-Cell Lung Cancer\",\"Thyroid Cancer\",\"Glioma\",\"Advanced Colorectal Cancer (Part 1)\"]","importance":30},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT06215118","excerpt":"[\"Multiple Myeloma\"]","importance":30},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fasting Conditions","security_title":"PHASE1","status":"NOT_YET_RECRUITING","accession_number":"NCT07587697","excerpt":"[\"Healthy Adults\"]","importance":30},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About Study Medicine Lorlatinib, as a First-line Treatment in Chinese Adults With ALK-positive a/mNSCLC","security_title":null,"status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT07556549","excerpt":"[\"Non-Small Cell Lung Cancer ALK-positive\"]","importance":25},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)","security_title":"PHASE4","status":"RECRUITING","accession_number":"NCT06057402","excerpt":"[\"Multiple Myeloma\"]","importance":25},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How Patients With Triple Class Refractory Multiple Myeloma (TCR-MM) Are Treated in Italian Centers for Blood Related Diseases","security_title":null,"status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT05742217","excerpt":"[\"Relapse Multiple Myeloma\",\"Refractory Multiple Myeloma\"]","importance":25},{"ts":"2026-05-13","kind":"clinical.trial","reporter":"Pfizer","title":"A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata","security_title":"PHASE3","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT06873945","excerpt":"[\"Alopecia Areata\"]","importance":60}]}